Furthermore, a recent study corroborated these findings by showing elevated HDAC catalytic activity in univentricular CHD patients, where HDAC inhibitors are suggested as a possible therapy for this kind of CHD [88]. This evidence concerns the gene HDAC9 and coronary artery disorder.